Cameron C Trenor

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Medical management of vascular anomalies
    Cameron C Trenor
    Boston Children s Hospital, Boston, Massachusetts, USA
    Semin Cutan Med Surg 35:177-81. 2016
  2. doi request reprint Complex lymphatic anomalies
    Cameron C Trenor
    Division of Pediatric Hematology Oncology, Boston Children s Hospital, Dana Farber Cancer Institute, Harvard Medical School, 300 Longwood Ave, Boston, Massachusetts 02115 Electronic address
    Semin Pediatr Surg 23:186-90. 2014
  3. doi request reprint Thrombosis and thrombophilia: principles for pediatric patients
    Cameron C Trenor
    Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    Blood Coagul Fibrinolysis 21:S11-5. 2010
  4. pmc Hormonal contraception and thrombotic risk: a multidisciplinary approach
    Cameron C Trenor
    Division of Hematology Oncology, Department of Medicine and Surgery, Children s Hospital Boston, Boston, Massachusetts 02115, USA
    Pediatrics 127:347-57. 2011
  5. doi request reprint Imaging features of kaposiform lymphangiomatosis
    Pradeep Goyal
    Vascular Anomalies Center, Boston Children s Hospital and Harvard Medical School, Boston, MA, USA
    Pediatr Radiol 46:1282-90. 2016
  6. ncbi request reprint The Boston Marathon Study: a novel approach to research during residency
    Andrew Y Shin
    Department of Medicine, Children s Hospital Boston, Boston, MA 02115, USA
    Pediatrics 117:1818-22. 2006
  7. doi request reprint Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention
    Naamah L Zitomersky
    Division of Gastroenterology, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 17:458-70. 2011
  8. doi request reprint Tissue factor-bearing microparticles and thrombus formation
    Jeffrey I Zwicker
    Division of Hemostasis, Harvard Medical School, Thrombosis Beth Israel Deaconess Medical Center, 330 Brookline Ave E CLS 903, Boston, MA 02215, USA
    Arterioscler Thromb Vasc Biol 31:728-33. 2011
  9. pmc Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
    Denise M Adams
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio Boston Children s Hospital and Harvard Medical School, Boston, Massachusetts
    Pediatrics 137:e20153257. 2016
  10. doi request reprint Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease
    Naamah L Zitomersky
    Division of Gastroenterology, Boston Children s Hospital, Boston, MA 02115, USA
    J Pediatr Gastroenterol Nutr 57:343-7. 2013

Collaborators

Detail Information

Publications13

  1. doi request reprint Medical management of vascular anomalies
    Cameron C Trenor
    Boston Children s Hospital, Boston, Massachusetts, USA
    Semin Cutan Med Surg 35:177-81. 2016
    ..Also, combinations of medications and protocols combining medical and procedural approaches are in development for refractory patients. ..
  2. doi request reprint Complex lymphatic anomalies
    Cameron C Trenor
    Division of Pediatric Hematology Oncology, Boston Children s Hospital, Dana Farber Cancer Institute, Harvard Medical School, 300 Longwood Ave, Boston, Massachusetts 02115 Electronic address
    Semin Pediatr Surg 23:186-90. 2014
    ..Improved characterization of natural history, predictors of poor outcomes, responses to therapy, and further clinical trials are needed for complex lymphatic anomalies. ..
  3. doi request reprint Thrombosis and thrombophilia: principles for pediatric patients
    Cameron C Trenor
    Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    Blood Coagul Fibrinolysis 21:S11-5. 2010
    ..As trials begin to define recurrence risks, outcome predictors and optimal therapy for children with thrombosis and thrombophilia, consultation with an experienced pediatric hematologist provides the best available therapy today...
  4. pmc Hormonal contraception and thrombotic risk: a multidisciplinary approach
    Cameron C Trenor
    Division of Hematology Oncology, Department of Medicine and Surgery, Children s Hospital Boston, Boston, Massachusetts 02115, USA
    Pediatrics 127:347-57. 2011
    ..Our multidisciplinary group has found that knowledge of the guidelines and individualized management plans have been particularly useful for informing discussions about hormonal and nonhormonal options across varied indications...
  5. doi request reprint Imaging features of kaposiform lymphangiomatosis
    Pradeep Goyal
    Vascular Anomalies Center, Boston Children s Hospital and Harvard Medical School, Boston, MA, USA
    Pediatr Radiol 46:1282-90. 2016
    ..Kaposiform lymphangiomatosis is a rare, aggressive lymphatic disorder. The imaging and presenting features of kaposiform lymphangiomatosis can overlap with those of central conducting lymphatic anomaly and generalized lymphatic anomaly...
  6. ncbi request reprint The Boston Marathon Study: a novel approach to research during residency
    Andrew Y Shin
    Department of Medicine, Children s Hospital Boston, Boston, MA 02115, USA
    Pediatrics 117:1818-22. 2006
    ..Careful topic selection with a well-defined end point, faculty involvement, resident collegiality, and institutional support were factors identified by study leaders as central to the success of this model...
  7. doi request reprint Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention
    Naamah L Zitomersky
    Division of Gastroenterology, Children s Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 17:458-70. 2011
    ..Until prospective trials of prophylactic anticoagulation are published, management of thrombotic risk and prophylaxis in IBD will remain a clinical challenge...
  8. doi request reprint Tissue factor-bearing microparticles and thrombus formation
    Jeffrey I Zwicker
    Division of Hemostasis, Harvard Medical School, Thrombosis Beth Israel Deaconess Medical Center, 330 Brookline Ave E CLS 903, Boston, MA 02215, USA
    Arterioscler Thromb Vasc Biol 31:728-33. 2011
    ..Only a subpopulation of these microparticles expresses tissue factor...
  9. pmc Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
    Denise M Adams
    Cincinnati Children s Hospital Medical Center, Cincinnati, Ohio Boston Children s Hospital and Harvard Medical School, Boston, Massachusetts
    Pediatrics 137:e20153257. 2016
    ..This Phase II trial enrolled patients with complicated vascular anomalies to determine the efficacy and safety of treatment with sirolimus for 12 courses; each course was defined as 28 days...
  10. doi request reprint Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease
    Naamah L Zitomersky
    Division of Gastroenterology, Boston Children s Hospital, Boston, MA 02115, USA
    J Pediatr Gastroenterol Nutr 57:343-7. 2013
    ..We characterized thromboembolism (TE) in children and young adults with inflammatory bowel disease (IBD) at a single tertiary care hospital...
  11. pmc Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system
    Esther A Obeng
    Division of Hematology Oncology, Boston Children s Hospital, Boston, MA Department of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA
    J Pediatr 166:144-50. 2015
    ..To characterize heparin-induced thrombocytopenia (HIT) at a single pediatric center including the prevalence and the accuracy of the 4Ts scoring system as a predictor of HIT...
  12. doi request reprint Quality improvement program reduces venous thromboembolism in infants and children with long-gap esophageal atresia (LGEA)
    Daniel P Kelly
    Division of Medicine Critical Care, Department of Medicine, Boston Children s Hospital, Harvard Medical School, Boston, MA, 02115, USA
    Pediatr Surg Int 32:691-6. 2016
    ..An institutional quality improvement program to decrease VTE risk factor exposure and utilize prophylactic anticoagulation was implemented. We aim to evaluate the efficacy and safety of a VTE risk-reduction program in patients with LGEA...
  13. pmc Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly
    Stacy E Croteau
    Dana Farber Boston Children s Cancer and Blood Disorders Center, Boston Children s Hospital, Boston, MA Harvard Medical School, Boston, MA Electronic address
    J Pediatr 164:383-8. 2014
    ..To describe the clinical and imaging characteristics of a new lymphatic disorder with a unique histological pattern and poor prognosis...